In general, our findings demonstrate that cytotoxic molecules, such as perforin, granzyme-B and granulysin, along with other immunological markers, such as C4 and IL-6, could be pivotal in characterizing the disease phases of SLE. This evidence concerns the gene GNLY and systemic lupus erythematosus.